Search results for "Impaired renal function"

showing 7 items of 7 documents

Physiological pharmacokinetic model for ceftazidime disposition in the rat and its application to prediction of plasma concentrations in humans

1993

Abstract A physiological pharmacokinetic model for the disposition of ceftazidime in the rat was developed. The model is composed of 10 compartments which represent most of the organs and tissues of the body. Ceftazidime concentration-time profiles in the organs and tissues represented in the model were simulated and compared with the observed concentration-time data after i.v. administration of 5 and 20 mg of antibiotic. The model gave an acceptable description of the observed data. The steady-state volume of distribution and total clearance of ceftazidime in healthy humans predicted from data obtained in the rat (0.21 l/kg and 113 ml/min, respectively) were similar to the values reported …

Volume of distributionImpaired renal functionPharmacokineticsPlasma concentrationmedicinePharmaceutical ScienceDistribution (pharmacology)CeftazidimeDispositionPharmacologyBiologyAntibacterial agentmedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct

Renal haemodynamics and severity of carotid atherosclerosis in hypertensive patients with and without impaired renal function.

2014

Background and Aim. Renal resistance index (RRI), assessed by Duplex-Doppler sonography, has been classically considered as a mere expression of intrarenal vascular resistance. Recent studies, however, have showed that RRI is also influenced by upstream factors, especially arterial compliance, confirming its possible role as a marker of systemic vascular alterations. Several studies have shown that carotid intima-media thickness (cIMT) and carotid plaques (cP), assessed by ultrasonography, are documented markers of subclinical organ damage as well as expression of progressive atherosclerotic disease, and that they get worse with the progressive deterioration of renal function. The study was…

Carotid atherosclerosisAdultCarotid Artery DiseasesMalemedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Renal functionBlood PressureKidneyCarotid Intima-Media ThicknessBody Mass IndexImpaired renal functionRisk FactorsInternal medicinemedicineHumansRenal InsufficiencyStage (cooking)TriglyceridesSubclinical infectionAgedSettore MED/14 - NefrologiaNutrition and Dieteticsbusiness.industryCholesterol HDLHemodynamicsCholesterol LDLMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolareCompliance (physiology)Atherosclerosis.medicine.anatomical_structureCross-Sectional StudiesCreatinineHypertensioncardiovascular systemCardiologyVascular resistancePopulation studyFemaleSettore MED/36 - Diagnostica Per Immagini E RadioterapiaCardiology and Cardiovascular MedicinebusinessBiomarkersNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Determination of renal tissue ibandronate levels in rats with normal and mildly impaired renal function

2013

After entering the blood, bisphosphonates are immediately bound to bone or excreted unchanged by the kidney. During renal excretion about 0.5% of administrated dosage remains in kidney tissue. The renal tissue level of bisphosphonates (RTL) decreases over time and remains at about 0.15% after 3weeks, but the influence of renal insufficiency (RI) is unclear.We investigated the influence of mild to moderate RI on RTL of ibandronate (IBD). First a method for determination of RTL was implemented and validated. We measured RTL in rats with normal renal function (SHAM) and after unilateral nephrectomy (UNX). In each case one SHAM and one UNX groups received one or alternatively 9 times every 3wee…

medicine.medical_specialtyTime FactorsUrologyKidneyToxicologySeverity of Illness IndexImpaired renal functionNormal renal functionmedicineAnimalsTissue DistributionRenal InsufficiencyRats WistarIbandronic AcidPharmacologyKidneyBone Density Conservation AgentsDiphosphonatesbusiness.industryRenal tissueUnilateral nephrectomyRatsSurgeryDisease Models Animalmedicine.anatomical_structureRenal physiologyFemalebusinessHalf-LifeJournal of Pharmacological and Toxicological Methods
researchProduct

Single Intravenous Dose Kinetics and Accumulation of Atenolol in Patients with Impaired Renal Function and on Hemodialysis

1980

The concentration of atenolol in plasma and urine was determined following an intravenous (i.v.) dose given to 17 hypertensive patients with a glomerular filtration rate (GFR) between 5 and 105 ml/min and in 4 patients on hemodialysis. In patients with normal renal function the mean half life of elimination was calculated to be 6.8 h. This value increased to a mean of 50.1 h in patients with a GFR below 10 ml/min. In patients on hemodialysis the half life of elimination was about 4 h. The elimination rate constants as well as the body and renal clearances of atenolol have a significant correlation with the GFR. Although accumulation of atenolol was observed, especially after multiple oral d…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentUrologyHalf-lifeRenal functionUrineurologic and male genital diseasesAtenololImpaired renal functionPharmacokineticsmedicineIn patientHemodialysisbusinessmedicine.drug
researchProduct

Long-Term Followup of Children with Colon Conduit Urinary Diversion and Ureterosigmoidostomy

1977

Sixty-four children underwent colon conduit urinary diversion because of a neurogenic bladder owing to myelomeningocele and 39 children required a ureterosigmoidostomy because of bladder exstrophy. The average length of followup was 4.6 years after colon conduit and 5.6 years after ureterosigmoidostomy. Colon conduit diversion was secondary in 3 children and ureterosigmoidostomy was secondary in 5. Of the children with a colon conduit 9.4% and of those with ureterosigmoidostomy 12.8% had postoperative surgical complications. Late surgical complications were encountered after colon conduit in 14.5% and after ureterosigmoidostomy in 20%. Of the children with normal renal function preoperative…

Malemedicine.medical_specialtyMeningomyeloceleAdolescentColonUrologymedicine.medical_treatmentUrinary DiversionKidneyNormal renal functionImpaired renal functionUreterosigmoidostomyPostoperative ComplicationsElectrical conduitColon SigmoidHumansMedicinecardiovascular diseasesUrinary Bladder NeurogenicChildbusiness.industryBladder ExstrophyUrinary diversionmedicine.diseaseSurgeryBladder exstrophysurgical procedures operativeLong term followupChild Preschoolcardiovascular systemFemalebusinessFollow-Up StudiesJournal of Urology
researchProduct

Treatment of cT1a Renal Tumours in Germany: A Nationwide Survey.

2015

<b><i>Objective:</i></b> To identify clinical parameters influencing German urologists treating cT1a renal tumours, we performed a nationwide survey among members of the German urological associations (DGU and BDU). <b><i>Material and Methods:</i></b> In spring 2012, DGU and BDU members were invited to complete our survey. For 8 cases and 3 index patients, participants were asked about their preferred treatment. Multivariate analyses were used to identify significant parameters leading the responders to favour radical nephrectomy (RN) over nephron sparing surgery (NSS) as well as active surveillance (AS) over invasive treatment. <b><i…

AdultMalemedicine.medical_specialtyMultivariate analysismedicine.medical_treatmentBiopsyUrology030232 urology & nephrologyRenal functionNationwide surveyKidneyNephrectomy03 medical and health sciencesImpaired renal function0302 clinical medicineInternal medicineGermanySurveys and QuestionnairesBiopsymedicineHumansAgedKidneymedicine.diagnostic_testbusiness.industryNephronsMiddle AgedNephrectomyKidney NeoplasmsSurgerymedicine.anatomical_structure030220 oncology & carcinogenesisMultivariate AnalysisFemaleNephron sparing surgerybusinessTomography X-Ray ComputedUrologia internationalis
researchProduct

Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients

2018

The efficacy and safety of olmesartan medoxomil (OM) vs active control (AC) monotherapy among elderly patients aged 60‐79 years (N = 4487) was evaluated by meta‐analysis (25 studies). In all patients, change from baseline to end point in blood pressure (BP) was significantly greater with OM vs AC (−19.5/−11.9 vs −16.8/−10.7 mm Hg). Greater proportions of OM‐ vs AC‐treated patients achieved BP goals. In patients with impaired renal function (estimated glomerular filtration rate <60 mL/min/1.73 m(2)), OM treatment resulted in a greater mean change from baseline in systolic BP vs AC (−21.2 vs −18.7 mm Hg, respectively) and a greater proportion of patients achieving BP goals. These parameters w…

medicine.medical_specialtyAngiotensin receptorEndocrinology Diabetes and MetabolismUrologyRenal functionBlood Pressure030204 cardiovascular system & hematologyHypertension Therapy03 medical and health sciencesImpaired renal functionAngiotensin Receptor Antagonists0302 clinical medicineDiabetes mellitusInternal MedicinemedicineHumansIn patient030212 general & internal medicineAdverse effectAgedOlmesartan Medoxomilbusiness.industryMiddle Agedmedicine.diseaseBlood pressureTreatment OutcomeHypertensionCardiology and Cardiovascular MedicineOlmesartanbusinessmedicine.drug
researchProduct